Hepatitis B surface antigen (HBsAg) prevalence in Papua New Guinea
Papua New Guinea: Hepatitis B surface antigen (HBsAg) prevalence was 2.5% in 2024. ▲ Rising
Hepatitis B surface antigen (HBsAg) prevalence in Papua New Guinea, 2015–2024
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for hepatitis b surface antigen (hbsag) prevalence in Papua New Guinea is 2.5%, measured in 2024. That is the highest value across all 10 years on record.
Compared with earlier readings it is up 31.6% over ten years.
Over the whole period, hepatitis b surface antigen (hbsag) prevalence in Papua New Guinea peaked at 2.5% in 2022 and was at its lowest, 1.9%, in 2015.
That places Papua New Guinea 10th out of 194 countries with data for 2024, putting it in the top 10%.
Hepatitis B surface antigen (HBsAg) prevalence in Papua New Guinea, year by year
| Year | Value | Change |
|---|---|---|
| 2015 | 1.9% | — |
| 2016 | 1.9% | +0.0% |
| 2017 | 1.9% | +0.0% |
| 2018 | 2.0% | +5.3% |
| 2019 | 2.1% | +5.0% |
| 2020 | 2.2% | +4.8% |
| 2021 | 2.4% | +9.1% |
| 2022 | 2.5% | +4.2% |
| 2023 | 2.5% | +0.0% |
| 2024 | 2.5% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 2.0% | 1.9% | 2.1% | 5 |
| 2020s | 2.4% | 2.2% | 2.5% | 5 |
Countries ranked near Papua New Guinea
More health data for Papua New Guinea
- Un projection of annual infant deaths, annual growth rate -1.77 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.3741 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,127 deaths per 1,000 people (2090)
- Number of infants who die before age 1 2,501 deaths (2100)
- Total tetanus - number of reported cases, gaps filled 27 (2025)
- Total tetanus - number of reported cases, per capita 0 units per person (2025)
- Diphtheria - number of reported cases, gaps filled 0 (2025)
- Diphtheria - number of reported cases, per capita 0 units per person (2025)
- Measles - number of reported cases, gaps filled 0 (2025)
- Measles - number of reported cases, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is hepatitis b surface antigen (hbsag) prevalence in Papua New Guinea?
- Hepatitis b surface antigen (hbsag) prevalence in Papua New Guinea was 2.5% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest hepatitis b surface antigen (hbsag) prevalence recorded in Papua New Guinea?
- The highest recorded value was 2.5% in 2022.
- What is the lowest hepatitis b surface antigen (hbsag) prevalence recorded in Papua New Guinea?
- The lowest recorded value was 1.9% in 2015.
- How does Papua New Guinea rank for hepatitis b surface antigen (hbsag) prevalence?
- Papua New Guinea ranks 10th out of 194 countries with data for 2024.
- Is hepatitis b surface antigen (hbsag) prevalence rising or falling in Papua New Guinea?
- Over the last ten years it is up 31.6%. The long-run trend across the full record is rising.
- Where does this Papua New Guinea data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).